Research graph
References from Adopting a model of antimicrobial stewardship program to anti-tubercular treatment stewardship: A single-centre experience from a private tertiary care hospital in South India. Local targets link to admitted publications; unresolved targets remain external evidence.
Unresolved reference
External reference
Tuberculosis in the era of COVID-19 in India
10.1016/j.dsx.2020.07.034 · 2020 · External reference
Unresolved reference
External reference
National TB elimination programme-What has changed
10.1016/j.ijmmb.2022.10.008 · 2023 · External reference
Unresolved reference
External reference
Engaging the Private Health Service Delivery Sector for TB Care in India—Miles to Go!
10.3390/tropicalmed8050265 · 2023 · External reference
Unresolved reference
External reference
Tuberculosis treatment in the private healthcare sector in India: an analysis of recent trends and volumes using drug sales data
10.1186/s12879-019-4169-y · 2019 · External reference
STEPS–a patient centric and low-cost solution to ensure standards of TB care to patients reaching private sector in India
10.1186/s12913-021-07342-y · 2022 · External reference
Emergence of drug resistance in patients with tuberculosis cared for by the Indian health-care system: a dynamic modelling study
10.1016/s2468-2667(16)30035-4 · 2017 · External reference
Multi-drug resistance tuberculosis (MDR-TB) challenges in India: A review
2023 · External reference
Tuberculosis and comorbidities: treatment challenges in patients with comorbid diabetes mellitus and depression
10.1177/20499361221095831 · 2022 · External reference
Knowledge, attitude, and practices of health-care providers toward antibiotic prescribing, antibiotic resistance, and multidrug-resistant tuberculosis
10.4103/picr.picr_122_19 · 2021 · External reference
Unresolved reference
External reference
Global prevalence of drug-resistant tuberculosis: a systematic review and meta-analysis
10.1186/s40249-023-01107-x · 2023 · External reference
The challenges of pharmacokinetic variability of first-line anti-TB drugs
10.1080/17512433.2017.1246179 · 2017 · External reference
Better understanding extrapulmonary tuberculosis: A scoping review of public health impact in Pakistan, Afghanistan, India, and Bangladesh
10.1002/hsr2.1357 · 2023 · External reference
Improved appropriateness of anti-tuberculosis prescription by the expert prescription review program in Taiwan
10.1016/j.jfma.2019.12.011 · 2020 · External reference
Impact of antimicrobial stewardship on reducing antimicrobial resistance
2023 · External reference
Five Rights of Antibiotic Safety: Antimicrobial Stewardship at One NHS Foundation Trust in England Before and During the COVID-19 Pandemic
10.1093/ijpp/riad074.001 · 2023 · External reference
10.4065/mcp.2011.0358
10.4065/mcp.2011.0358 · External reference
Policy document on antimicrobial stewardship practices in India
10.4103/ijmr.ijmr_147_18 · 2019 · External reference
Unresolved reference
External reference
Clinical standards for the dosing and management of TB drugs
10.5588/ijtld.22.0188 · 2022 · External reference
10.1093/ofid/ofy290
10.1093/ofid/ofy290 · External reference
Mapping the implementation of a clinical pharmacist-driven antimicrobial stewardship programme at a tertiary care centre in South India
10.3390/antibiotics10020220 · 2021 · External reference
Antimicrobial stewardship
2023 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
ERS/WHO Tuberculosis Consilium assistance in extensively drug-resistant tuberculosis
10.1183/09031936.00107814 · 2015 · External reference
